Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2

Lignende værker

• A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
  af: Tamura, Ryota, et al.
  Udgivet: (2019)
• Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
  af: Tamura, Ryota, et al.
  Udgivet: (2020)
• Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
  af: Tamura, Ryota, et al.
  Udgivet: (2020)
• A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma
  af: Tamura, Ryota, et al.
  Udgivet: (2020)
• IMT-02 VEGF RECEPTORS EXPRESSION AND REPORT OF CLINICAL TRIAL OF PEPTIDE VACCINE IN SKULL BASE CHORDOMA
  af: Morimoto, Yukina, et al.
  Udgivet: (2019)